Choo Joanna A L, Liu Jingxian, Toh Xinyu, Grotenbreg Gijsbert M, Ren Ee Chee
Department of Microbiology, National University of Singapore, Singapore Immunology Programme, National University of Singapore, Singapore.
Singapore Immunology Network, A*STAR, Singapore.
J Virol. 2014 Sep;88(18):10613-23. doi: 10.1128/JVI.00855-14. Epub 2014 Jul 2.
Cytotoxic T lymphocytes recognizing conserved peptide epitopes are crucial for protection against influenza A virus (IAV) infection. The CD8 T cell response against the M158-66 (GILGFVFTL) matrix protein epitope is immunodominant when restricted by HLA-A02, a major histocompatibility complex (MHC) molecule expressed by approximately half of the human population. Here we report that the GILGFVFTL peptide is restricted by multiple HLA-C08 alleles as well. We observed that M158-66 was able to elicit cytotoxic T lymphocyte (CTL) responses in both HLA-A02- and HLA-C08-positive individuals and that GILGFVFTL-specific CTLs in individuals expressing both restriction elements were distinct and not cross-reactive. The crystal structure of GILGFVFTL-HLA-C08:01 was solved at 1.84 Å, and comparison with the known GILGFVFTL-HLA-A02:01 structure revealed that the antigen bound both complexes in near-identical conformations, accommodated by binding pockets shaped from shared as well as unique residues. This discovery of degenerate peptide presentation by both HLA-A and HLA-C allelic variants eliciting unique CTL responses to IAV infection contributes fundamental knowledge with important implications for vaccine development strategies.
The presentation of influenza A virus peptides to elicit immunity is thought to be narrowly restricted, with a single peptide presented by a specific HLA molecule. In this study, we show that the same influenza A virus peptide can be more broadly presented by both HLA-A and HLA-C molecules. This discovery may help to explain the differences in immunity to influenza A virus between individuals and populations and may also aid in the design of vaccines.
识别保守肽表位的细胞毒性T淋巴细胞对于预防甲型流感病毒(IAV)感染至关重要。当受HLA - A02限制时,针对M158 - 66(GILGFVFTL)基质蛋白表位的CD8 T细胞反应具有免疫优势,HLA - A02是一种主要组织相容性复合体(MHC)分子,约一半的人类表达该分子。在此我们报告,GILGFVFTL肽也受多种HLA - C08等位基因限制。我们观察到,M158 - 66能够在HLA - A02阳性和HLA - C08阳性个体中引发细胞毒性T淋巴细胞(CTL)反应,并且在同时表达这两种限制元件的个体中,GILGFVFTL特异性CTL是不同的,且无交叉反应性。GILGFVFTL - HLA - C08:01的晶体结构在1.84 Å分辨率下解析,与已知的GILGFVFTL - HLA - A*02:01结构比较显示,抗原以近乎相同的构象结合这两种复合体,由共享以及独特残基形成的结合口袋容纳。HLA - A和HLA - C等位基因变体呈现简并肽引发对IAV感染的独特CTL反应这一发现,为疫苗开发策略提供了具有重要意义的基础知识。
甲型流感病毒肽引发免疫的呈递被认为受到严格限制,即由特定HLA分子呈递单一肽。在本研究中,我们表明相同的甲型流感病毒肽可由HLA - A和HLA - C分子更广泛地呈递。这一发现可能有助于解释个体和群体对甲型流感病毒免疫的差异,也可能有助于疫苗设计。